Shawn Iganej - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shawn Iganej

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Oral Oncology|August 18, 2019

Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancerShawn Iganej, Bryce W Beard, Jergin Chen, et al.

Head and Neck Pathology|December 2, 2025

Ghost Cell Odontogenic Carcinoma: Case Series and Literature ReviewDalja Parks, Nancy J Zhou, Danny A Vazquez, et al.

Oral Oncology|January 18, 2021

Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimizationOnita Bhattasali, Fernando A Torres, Hyung K Kang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Oral Oncology|August 18, 2019

Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancerShawn Iganej, Bryce W Beard, Jergin Chen, et al.

Head and Neck Pathology|December 2, 2025

Ghost Cell Odontogenic Carcinoma: Case Series and Literature ReviewDalja Parks, Nancy J Zhou, Danny A Vazquez, et al.

Oral Oncology|January 18, 2021

Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimizationOnita Bhattasali, Fernando A Torres, Hyung K Kang, et al.

Pageof 2